(Q48705609)

14 February 2018

title

Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans. (English)

1 reference

14 February 2018

0 references

Nishino S

1

1 reference

14 February 2018

Riehl J

2

1 reference

14 February 2018

Hong J

3

1 reference

14 February 2018

Kwan M

4

1 reference

14 February 2018

Reid M

5

1 reference

14 February 2018

Mignot E

6

1 reference

14 February 2018

publication date

1 December 2000

1 reference

14 February 2018

published in

Neuroscience Research

1 reference

14 February 2018

volume

38

1 reference

14 February 2018

page(s)

437-446

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

The neurobiology of narcolepsy-cataplexy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

High prevalence of isolated sleep paralysis: kanashibari phenomenon in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Sleep satiation in narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Dopamine D3 agonists into the substantia nigra aggravate cataplexy but do not modify sleep [corrected].

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Neurophysiology of the states of sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Pharmacological aspects of human and canine narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Hypnagogic and hypnopompic hallucinations: pathological phenomena?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

1 reference

7 January 2021

Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

NOCTURNAL SLEEP OF NARCOLEPTICS

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Local administration of dopaminergic drugs into the ventral tegmental area modulates cataplexy in the narcoleptic canine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Development of cataplexy in genetically narcoleptic Dobermans

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

REM sleep and NREM sleep in narcolepsy and hypersomnia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Activity of substantia nigra units across the sleep-waking cycle in freely moving cats

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

Studies in psychophysiology of dreams. III. The dream of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-0102%2800%2900195-4

7 January 2021

10.1016/S0168-0102(00)00195-4

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

11164570

1 reference

14 February 2018